 REDWOOD CITY, Calif., Sept. 24, 2021 GLOBE NEWSWIRE -- Coherus BioSciences, Inc. Coherus or the Company, Nasdaq: CHRS, today announced that effective Sept. 22, 2021, the compensation committee of the Companys board of directors granted options to purchase an aggregate of 229,500 shares of the common stock of the Company to newly hired employees with a per share exercise price of 17.06, the closing trading price on the grant date. A newly hired Senior Vice President was granted options for 100,000 shares; eight additional non-officer employees were granted options to purchase an aggregate of 129,500 shares. 